Interesting article in The American Scholar on how big pharma influences publishers, editorials and marketing of its products. I pulled out two very small excerpts of the piece:
"But aren’t physicians, with their scientific training and medical expertise, able to see through the negative bias and data manipulation? Not according to the editor of the Journal of the National Medical Association. “A busy pediatrician who is seeing patients until eight at night doesn’t have time to figure out whether an article has been vetted,” explains Eddie L. Hoover, MD. “He depends upon the journal editors to make sure he is not reading trash.”
"When you are published in a medical journal, especially one of the top ones, this gives the article a certain imprimatur that makes people less critical,” adds Joel Lexchin, MD, a bioethicist at York University in Toronto. “‘If it’s in The New England Journal of Medicine it’s got to be good’: This mentality diminishes the critical reading of the study.”
I remember reading a similar article 10 years ago while I researched a few pharma stocks.
No comments:
Post a Comment
Mysterious and anonymous comments as well as those laced with cyanide and ad hominen attacks will be deleted. Thank you for your attention, chumps.